Type to search

Avacta Establishes New Therapeutics Headquarters at Scale Space, Imperial College White City Campus | Pharmtech Focus
Avacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000 | Pharmtech Focus